In a major push for women’s health, the Government of India has officially launched a nationwide Human Papillomavirus (HPV) vaccination campaign aimed at eliminating cervical cancer. Prime Minister Narendra Modi inaugurated the initiative on February 28, 2024, in Ajmer, Rajasthan, marking the start of a phased rollout that will provide free vaccines to adolescent girls across the country.
Cervical cancer is the second most common cancer among women in India, accounting for nearly 25% of global deaths from the disease. To combat this, the government is administering a single dose of the Quadrivalent HPV vaccine (Gardasil)which offers high efficacy against HPV types 16 and 18, the strains responsible for over 80% of cervical cancer cases in India.
Health experts emphasize that the vaccine is most effective when administered before girls become sexually active. While the national program focuses on a single-dose schedule for 14-year-olds to maximize coverage, the vaccine remains recommended for individuals up to age 45, though the dosage schedule varies for older age groups.
Despite the medical benefits, officials and health advocates are focusing heavily on “outreach and awareness” to combat vaccine hesitancy. Common misconceptions regarding fertility and side effects remain a hurdle. To address this, the government has launched field-level awareness programs to educate families on the vaccine’s safety and its role in long-term health protection.
Key Facts at a Glance:
First is target Groups, nationwide rollout for all 14-year-old girls. Second is free of cost at all government health facilities. Third is disease Burden, India reports over 1.2 lakh new cervical cancer cases and 80,000 deaths annually. Fourth vaccine used: Approved quadrivalent vaccine targeting major cancer-causing HPV strains.
The initiative is being hailed as a landmark public health intervention, aligning India with over 160 countries that have already integrated HPV vaccination into their national immunization schedules.
Comments are closed.